169 related articles for article (PubMed ID: 30207105)
21. Preoperative chemoradiation followed by hysterectomy for cervical cancer: patterns of care and survival in a large, hospital database.
Albert A; Allbright R; Lee A; Vijayakumar S
J Gynecol Oncol; 2019 May; 30(3):e41. PubMed ID: 30887759
[TBL] [Abstract][Full Text] [Related]
22. Management of Unresectable T4b Esophageal Cancer: Practice Patterns and Outcomes From the National Cancer Data Base.
Cushman TR; Shaaban SG; Moreno AC; Lin C; Verma V
Am J Clin Oncol; 2019 Feb; 42(2):154-159. PubMed ID: 30499838
[TBL] [Abstract][Full Text] [Related]
23. Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients.
Ryu HS; Chun M; Chang KH; Chang HJ; Lee JP
Gynecol Oncol; 2005 Feb; 96(2):490-5. PubMed ID: 15661240
[TBL] [Abstract][Full Text] [Related]
24. Survival of women with Mullerian adenosarcoma: A National Cancer Data Base study.
Seagle BL; Kanis M; Strohl AE; Shahabi S
Gynecol Oncol; 2016 Dec; 143(3):636-641. PubMed ID: 27771166
[TBL] [Abstract][Full Text] [Related]
25. Pathological Risk Factors and Outcomes in Women With Stage IB2 Cervical Cancer Treated With Primary Radical Surgery Versus Chemoradiotherapy.
Bradbury M; Founta C; Taylor W; Kucukmetin A; Naik R; Ang C
Int J Gynecol Cancer; 2015 Oct; 25(8):1476-83. PubMed ID: 26244756
[TBL] [Abstract][Full Text] [Related]
26. Parametrial involvement in women with low-risk, early-stage cervical cancer.
Vanichtantikul A; Tantbirojn P; Manchana T
Eur J Cancer Care (Engl); 2017 Sep; 26(5):. PubMed ID: 27704641
[TBL] [Abstract][Full Text] [Related]
27. Radical hysterectomy followed by tailored postoperative therapy in the treatment of stage IB2 cervical cancer: feasibility and indications for adjuvant therapy.
Yessaian A; Magistris A; Burger RA; Monk BJ
Gynecol Oncol; 2004 Jul; 94(1):61-6. PubMed ID: 15262120
[TBL] [Abstract][Full Text] [Related]
28. Survival Benefit of Adjuvant Brachytherapy After Hysterectomy With Positive Surgical Margins in Cervical Cancer.
Li R; Shinde A; Chen YJ; Amini A; Lee S; Dellinger T; Han E; Wakabayashi M; Nelson R; Beriwal S; Glaser S
Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):373-382. PubMed ID: 29890264
[TBL] [Abstract][Full Text] [Related]
29. Locoregional spread and survival of stage IIA1 versus stage IIA2 cervical cancer.
Hongladaromp W; Tantipalakorn C; Charoenkwan K; Srisomboon J
Asian Pac J Cancer Prev; 2014; 15(2):887-90. PubMed ID: 24568513
[TBL] [Abstract][Full Text] [Related]
30. Stage IB and IIA cervical cancer with negative lymph nodes: the role of adjuvant radiotherapy after radical hysterectomy.
Schorge JO; Molpus KL; Koelliker D; Nikrui N; Goodman A; Fuller AF
Gynecol Oncol; 1997 Jul; 66(1):31-5. PubMed ID: 9234917
[TBL] [Abstract][Full Text] [Related]
31. The Impact of Patient Characteristics, Risk Factors, and Surgical Intervention on Survival in a Cohort of Patients Undergoing Neoadjuvant Treatment for Cervical Cancer.
Dicu-Andreescu IG; Marincaș MA; Prunoiu VM; Dicu-Andreescu I; Ionescu SO; Simionescu AA; Brătucu E; Simion L
Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138250
[No Abstract] [Full Text] [Related]
32. Association of Adjuvant Chemoradiotherapy vs Radiotherapy Alone With Survival in Patients With Resected Major Salivary Gland Carcinoma: Data From the National Cancer Data Base.
Amini A; Waxweiler TV; Brower JV; Jones BL; McDermott JD; Raben D; Ghosh D; Bowles DW; Karam SD
JAMA Otolaryngol Head Neck Surg; 2016 Nov; 142(11):1100-1110. PubMed ID: 27541166
[TBL] [Abstract][Full Text] [Related]
33. Impact of time interval between radical hysterectomy with pelvic node dissection and initial adjuvant therapy on oncological outcomes of early stage cervical cancer.
Hanprasertpong J; Jiamset I; Geater A; Leetanaporn K; Peerawong T
J Gynecol Oncol; 2017 Jul; 28(4):e42. PubMed ID: 28541633
[TBL] [Abstract][Full Text] [Related]
34. Open versus laparoscopic pelvic lymph node dissection in early stage cervical cancer: no difference in surgical or disease outcome.
van de Lande J; von Mensdorff-Pouilly S; Lettinga RG; Piek JM; Verheijen RH
Int J Gynecol Cancer; 2012 Jan; 22(1):107-14. PubMed ID: 21857347
[TBL] [Abstract][Full Text] [Related]
35. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of Stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases: an analysis of 891 cases.
Lai CH; Hong JH; Hsueh S; Ng KK; Chang TC; Tseng CJ; Chou HH; Huang KG
Cancer; 1999 Apr; 85(7):1537-46. PubMed ID: 10193944
[TBL] [Abstract][Full Text] [Related]
36. Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: a multicenter retrospective study (KROG 13-10).
Noh JM; Park W; Kim YS; Kim JY; Kim HJ; Kim J; Kim JH; Yoon MS; Choi JH; Yoon WS; Kim JY; Huh SJ
Gynecol Oncol; 2014 Mar; 132(3):618-23. PubMed ID: 24486605
[TBL] [Abstract][Full Text] [Related]
37. [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa].
Chen L; Lü WG; Xie X; Chen HZ; Yu H; Ni XH
Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):239-42. PubMed ID: 15924669
[TBL] [Abstract][Full Text] [Related]
38. Concurrent paclitaxel/cisplatin chemoradiotherapy with or without consolidation chemotherapy in high-risk early-stage cervical cancer patients following radical hysterectomy: preliminary results of a phase III randomized study.
Zhao H; Li L; Su H; Lin B; Zhang X; Xue S; Fei Z; Zhao L; Pan Q; Jin X; Xie C
Oncotarget; 2016 Oct; 7(43):70969-70978. PubMed ID: 27391158
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant chemoradiation does not improve survival in elderly patients with high-risk resected head and neck cancer.
Giacalone NJ; Qureshi MM; Mak KS; Kirke D; Patel SA; Shah BA; Salama AR; Jalisi S; Truong MT
Laryngoscope; 2018 Apr; 128(4):831-840. PubMed ID: 28833217
[TBL] [Abstract][Full Text] [Related]
40. Validity of laparoscopic staging to avoid adjuvant chemoradiation following radical surgery in patients with early cervical cancer.
Marnitz S; Köhler C; Affonso RJ; Schneider A; Chiantera V; Tsounoda A; Vercellino F
Oncology; 2012; 83(6):346-53. PubMed ID: 23006972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
